| Leveraging Partial SMILES Validation Scheme for Enhanced Drug Design in Reinforcement Learning Frameworks | May 1, 2025 | Deep Reinforcement LearningDrug Design | —Unverified | 0 |
| Combining GCN Structural Learning with LLM Chemical Knowledge for or Enhanced Virtual Screening | Apr 24, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Synergistic Benefits of Joint Molecule Generation and Property Prediction | Apr 23, 2025 | Drug Designmolecular representation | —Unverified | 0 |
| DrugGen enhances drug discovery with large language models and reinforcement learning | Apr 18, 2025 | Drug DesignDrug Discovery | CodeCode Available | 0 |
| How to Detect and Defeat Molecular Mirage: A Metric-Driven Benchmark for Hallucination in LLM-based Molecular Comprehension | Apr 10, 2025 | Computational EfficiencyDecoder | —Unverified | 0 |
| Interpretable Multimodal Learning for Tumor Protein-Metal Binding: Progress, Challenges, and Perspectives | Apr 4, 2025 | Drug Design | —Unverified | 0 |
| HCAF-DTA: drug-target binding affinity prediction with cross-attention fused hypergraph neural networks | Apr 2, 2025 | Drug DesignPrediction | —Unverified | 0 |
| TransDiffSBDD: Causality-Aware Multi-Modal Structure-Based Drug Design | Mar 26, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
| Two for the Price of One: Integrating Large Language Models to Learn Biophysical Interactions | Mar 26, 2025 | Computational EfficiencyDrug Design | —Unverified | 0 |
| Extracting Interpretable Logic Rules from Graph Neural Networks | Mar 25, 2025 | Drug DesignDrug Discovery | —Unverified | 0 |
